XML 30 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Cash flows from operating activities          
Net increase (decrease) in net assets resulting from operations $ 78,984 $ 93,558 $ 190,298 $ 169,334  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Amortization of deferred debt issuance costs 2,479 2,546 5,124 4,655  
Accretion of discounts and amortization of premiums on investments     (2,678) (7,450)  
Accretion of discounts and amortization of premiums on issued debt securities     1,681 455  
Net realized (gain) loss on investments     42,220 17,368  
Net realized (gain) loss on foreign currency transactions 174 (4,459) 3,879 (4,646)  
Net realized (gain) loss on forward currency contracts (5,997) 0 (7,203) 0  
Net realized (gain) loss on extinguishment of debt 0 0 48 0  
Net change in unrealized (appreciation) depreciation on investments     (38,906) (17,013)  
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies (11,427) 10,156 11,546 3,969  
Proceeds from (fundings of) revolving loans, net     (5,016) (1,658)  
Fundings of investments     (1,208,048) (147,267)  
Proceeds from principal payments and sales of portfolio investments     840,343 321,264  
Proceeds from settlements of forward currency contracts     10,264 0  
Payment-in-kind interest capitalized (14,710) (9,682) (27,921) (23,397)  
Non-cash dividends capitalized     (15,071) (8,603)  
Proceeds from non-cash dividends     3,549 0  
Changes in operating assets and liabilities:          
Cash collateral held at broker for derivatives     0 (4,800)  
Interest receivable     8,293 (4,027)  
Receivable for investments sold     0 (3,727)  
Other assets     385 283  
Interest payable     4,772 11,840  
Management and incentive fees payable     7,250 (6,106)  
Accrued trustee fees     89 (94)  
Accounts payable and other liabilities     (2,459) 8,479  
Net cash provided by (used in) operating activities     (179,296) 313,014  
Cash flows from financing activities          
Borrowings on debt     3,731,443 1,145,606  
Repayments of debt     (3,496,076) (999,698)  
Capitalized debt issuance costs     (5,995) (13,343)  
Net proceeds from issuance of common stock (Note 11)     37,434 0  
Purchases of common stock (Note 11)     (1,130) 0  
Distributions paid     (197,633) (123,572)  
Net cash provided by (used in) financing activities     68,043 8,993  
Net change in cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies     (111,253) 322,007  
Effect of foreign currency exchange rates     (1,915) (1,865)  
Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, beginning of period     359,552 [1] 140,206 $ 140,206
Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, end of period 246,384 [1] 460,348 246,384 [1] 460,348 359,552 [1]
Supplemental disclosure of cash flow information:          
Cash paid during the period for interest [2]     133,282 71,205  
Distributions declared for the period 231,337 153,092 231,337 153,092  
Supplemental disclosure of non-cash financing activities:          
Stock issued in connection with dividend reinvestment plan     33,704 29,520  
Reconciliation of cash and cash equivalents, foreign currencies and restricted cash and cash equivalents and restricted foreign currencies          
Cash and cash equivalents 103,136   103,136   123,120
Foreign currencies (cost of $13,763 and $7,973, respectively) 13,791   13,791   8,044
Restricted cash and cash equivalents 129,457   129,457   227,152
Restricted foreign currencies (cost of $0 and $1,219, respectively) 0   0   1,236
Total cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies shown in the Consolidated Statements of Cash Flows 246,384 [1] 460,348 246,384 [1] 460,348 $ 359,552 [1]
Interest Rate Swap          
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Net change in unrealized (appreciation) depreciation on derivatives     4,697 2,772  
Foreign exchange          
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Net realized (gain) loss on forward currency contracts (5,997) 0 (7,203) 0  
Net change in unrealized (appreciation) depreciation on derivatives $ 15,495 $ (4,332) $ (6,432) $ 1,383  
[1] See Note 2 for a description of cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies.
[2] Includes cash paid or received for contractual interest rate swaps, which may have different contractual settlement dates among the (i) fixed interest leg, (ii) floating interest leg and (iii) the debt instrument.